Comment on: Use of Plerixafor for Short‐Term Management of Leukopenia in a Pediatric Patient With WHIM Syndrome

Julia T. Warren; Christophe Arbet‐Engels; Deborah J. Steiner; Teresa K. Tarrant

doi:10.1002/pbc.31748

journal article Open Access May 04, 2025

Comment on: Use of Plerixafor for Short‐Term Management of Leukopenia in a Pediatric Patient With WHIM Syndrome

Julia T. Warren Christophe Arbet‐Engels Deborah J. Steiner Teresa K. Tarrant

Pediatric Blood & Cancer Vol. 72 No. 7 · Wiley

View at Publisher Save 10.1002/pbc.31748

Topics

No keywords indexed for this article. Browse by subject →

References

8

[1]

10.1002/pbc.31401

[2]

10.1007/s10875‐022‐01312‐7

[3]

10.3389/fimmu.2024.1411141

[4]

10.1182/blood‐2022‐155692

[5]

(2023)

[6]

(2024)

[7]

10.1182/blood.2020007197

[8]

10.1182/blood.2023022658

Metrics

0

Citations

8

References

Details

Published: May 04, 2025
Vol/Issue: 72(7)
License: View

Authors

J

Julia T. Warren

Department of Pediatrics Division of Hematology Perlman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; Division of Pediatric Hematology Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

C

Christophe Arbet‐Engels

X4 Pharmaceuticals Inc Boston Massachusetts USA

D

Deborah J. Steiner

X4 Pharmaceuticals Inc Boston Massachusetts USA

T

Teresa K. Tarrant

Department of Medicine Division of Rheumatology and Immunology Duke University Durham North Carolina USA; Department of Veteran Affairs Durham Medical Hospital Durham North Carolina USA

Cite This Article

Julia T. Warren, Christophe Arbet‐Engels, Deborah J. Steiner, et al. (2025). Comment on: Use of Plerixafor for Short‐Term Management of Leukopenia in a Pediatric Patient With WHIM Syndrome. Pediatric Blood & Cancer, 72(7). https://doi.org/10.1002/pbc.31748

Comment on: Use of Plerixafor for Short‐Term Management of Leukopenia in a Pediatric Patient With WHIM Syndrome

You May Also Like